Calcium receptor modulating agents
AssigneeAmgen Inc.
InventorsMichael G. Kelly, Shimin Xu, Ning Xi, Philip Miller, John F. Kincaid, Chiara Ghiron, Thomas Coulter
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmgen Inc.
InventorsMichael G. Kelly, Shimin Xu, Ning Xi, Philip Miller, John F. Kincaid, Chiara Ghiron, Thomas Coulter
Estimating the term…
The compounds of the invention are represented by the following general structure 1 or a pharmaceutically acceptable salt thereof, and compositions containing them, wherein the variables are defined herein, and their use to reduce or inhibit PTH secretion, including methods for reducing or inhibiting PTH secretion and methods for treatment or prophylaxis of diseases associated with bone disorders, such as osteoporosis, or associated with excessive secretion of PTH, such as hyperparathyroidism. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
A compound of formula (I):
A compound selected from the group consisting of:
A compound selected from the group consisting of:
A composition comprising a pharmaceutically acceptable amount of a compound of the formula Ia:
A compound having the formula
Dependencies are inferred from the claim text.